We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.44%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$28.3B
AUM Growth
+$2.33B
(+9%)
Cap. Flow
+$1.79B
Cap. Flow
% of AUM
6.32%
Top 10 Holdings %
Top 10 Hldgs %
25.96%
Holding
1,069
New
128
Increased
377
Reduced
389
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$356M |
| 2 |
Lam Research
LRCX
|
+$283M |
| 3 |
Palo Alto Networks
PANW
|
+$261M |
| 4 |
GE Vernova
GEV
|
+$216M |
| 5 |
Tractor Supply
TSCO
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$275M |
| 2 |
Intuit
INTU
|
+$214M |
| 3 |
CrowdStrike
CRWD
|
+$204M |
| 4 |
Williams-Sonoma
WSM
|
+$164M |
| 5 |
Old Dominion Freight Line
ODFL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.61% |
| 2 | Financials | 14.28% |
| 3 | Consumer Discretionary | 13.77% |
| 4 | Industrials | 12.88% |
| 5 | Healthcare | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Bank7 Corp
BSVN
$478M
| $201K | ﹤0.01% |
+4,300
| New | +$190K |
|
902
Babcock & Wilcox
BW
$1.31B
| $187K | ﹤0.01% |
114,251
-613,011
| -84% | -$1.3M |
|
903
Perimeter Solutions
PRM
$5.69B
| $185K | ﹤0.01% |
+14,494
| New | +$189K |
|
904
Clarus
CLAR
$128M
| $185K | ﹤0.01% |
41,023
-52,350
| -56% | -$235K |
|
905
Groupon
GRPN
$1.07B
| $184K | ﹤0.01% |
15,162
-2,592
| -15% | -$27.2K |
|
|
TRUE
906
DELISTED
TrueCar
TRUE
| $171K | ﹤0.01% |
45,846
-312,445
| -87% | -$1.23M |
|
907
Pebblebrook Hotel Trust
PEB
$2.2B
| $169K | ﹤0.01% |
12,468
-15,902
| -56% | -$210K |
|
908
Organogenesis Holdings
ORGO
$326M
| $156K | ﹤0.01% |
48,613
-232,865
| -83% | -$781K |
|
909
Identive
INVE
$64.1M
| $152K | ﹤0.01% |
41,395
-23,255
| -36% | -$87.2K |
|
910
Harvard Bioscience
HBIO
$26.7M
| $137K | ﹤0.01% |
+6,501
| New | +$149K |
|
911
Opendoor
OPEN
$3.8B
| $126K | ﹤0.01% |
81,578
-489,818
| -86% | -$888K |
|
912
Hecla Mining
HL
$9.76B
| $125K | ﹤0.01% |
25,542
| – | – |
|
913
AerSale
ASLE
$307M
| $124K | ﹤0.01% |
19,752
-15,697
| -44% | -$90K |
|
914
Q32 Bio
QTTB
$467M
| $120K | ﹤0.01% |
+34,844
| New | +$1.1M |
|
915
Aurinia Pharmaceuticals
AUPH
$1.92B
| $119K | ﹤0.01% |
+13,236
| New | +$108K |
|
916
Design Therapeutics
DSGN
$741M
| $113K | ﹤0.01% |
18,261
-262,010
| -93% | -$1.52M |
|
917
ARKO Corp
ARKO
$901M
| $109K | ﹤0.01% |
+16,500
| New | +$114K |
|
918
Granite Ridge Resources
GRNT
$601M
| $96.5K | ﹤0.01% |
14,943
-138,275
| -90% | -$856K |
|
919
Zevia
ZVIA
$116M
| $81.4K | ﹤0.01% |
+19,424
| New | +$39.6K |
|
920
Lifetime Brands
LCUT
$200M
| $77.8K | ﹤0.01% |
13,169
-2,482
| -16% | -$15K |
|
921
Pangaea Logistics
PANL
$493M
| $58.7K | ﹤0.01% |
+10,951
| New | +$66K |
|
922
TScan Therapeutics
TCRX
$50.6M
| $57.6K | ﹤0.01% |
18,951
-84,489
| -82% | -$383K |
|
923
Relmada Therapeutics
RLMD
$549M
| $23.7K | ﹤0.01% |
45,602
-112,070
| -71% | -$273K |
|
924
DHI Group
DHX
$178M
| $21.6K | ﹤0.01% |
12,193
-11,925
| -49% | -$21.1K |
|
925
Lulu's Fashion Lounge
LVLU
$50.3M
| $14.4K | ﹤0.01% |
+852
| New | +$17.4K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2024 Portfolio in Review
As of Q4 2024, Jacobs Levy Equity Management held 1,069 positions worth $28.3B, up 9% from $25.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jacobs Levy Equity Management deployed $1.79B of net new capital in Q4 2024, opening 128 new positions and adding to 377 existing holdings. Its largest new stake was Tractor Supply: 2,947,687 shares worth $156M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Amphenol, an estimated $275M trimmed.
- Jacobs Levy Equity Management's largest Q4 2024 buy was Tractor Supply: 2,947,687 shares worth $156M.
- Jacobs Levy Equity Management added most to Arista Networks in Q4 2024, an estimated $356M increase.
- Jacobs Levy Equity Management's biggest Q4 2024 reduction was Amphenol, cutting an estimated $275M.
- Jacobs Levy Equity Management fully exited Sarepta Therapeutics in Q4 2024, selling an estimated $94.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 26% of its $28.3B portfolio in Q4 2024.
- Jacobs Levy Equity Management opened 128 new positions and closed 143 in Q4 2024.
- Jacobs Levy Equity Management's portfolio value rose 9% quarter-over-quarter to $28.3B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2024, filed 14 Feb 2025.